BRKR Bruker Corporation - Common Stock

NAS · US · Healthcare · Medical Devices · bruker.com

63.24USD+2.10%Mkt Cap: 9.64B $P/E: —3d ago

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instrument…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

Key Statistics

Company

Market Cap9.64B USD

Enterprise Value11.36B USD

Revenue (TTM)3.50B USD

Gross Profit1.58B USD

Net Income (TTM)-8.60M USD

Revenue/Share23.01 USD

Last Price63.24 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees11.1K

CountryUS

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)26.43

PEG1.52

EV/EBITDA20.99

EV/Revenue3.25

P/S2.75

P/B4.05

EPS (TTM)-0.70

EPS (Forward)2.39

52W Range

30.0990% of range66.98

52W High66.98 USD

52W Low30.09 USD

Profitability

Gross Margin45.91%

Oper. Margin9.88%

EBITDA Margin15.46%

Profit Margin-0.25%

ROE-0.35%

ROA-0.14%

Growth

Revenue Growth5.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF134.10M USD

CapEx (TTM)120.20M USD

FCF Margin5.14%

FCF Yield1.87%

Net Debt1.67B USD

Net Debt/EBITDA3.09

Balance Sheet

Debt/Equity0.83

Current Ratio1.85

Quick Ratio0.80

Book Value/Sh15.63 USD

Cash/Share1.21 USD

Dividends

Fwd Div Rate0.20 USD

Trail. Div Rate0.20 USD

Div. Yield0.32%

5Y Avg Yield0.32%

Payout Ratio38.46%

Ex-Div DateSep 21, 2026

Pay DateOct 7, 2026

Analyst Consensus

Rating2.2 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)62.25 USD

Upside (mean)-1.6%

Target Range50.00 USD – 80.00 USD

50.00-1.6% to mean80.00

# Analysts12

Ownership

Shares Out.152.36M

Float103.69M

Insiders26.97%

Institutions95.23%

Short Interest

Short Ratio6.3d

Short % Float15.80%

Short % Out.8.20%

Shares Short12.49M

Short (prev mo.)11.79M

Technical

SMA 5058.90 (+7.4%)

SMA 20049.30 (+28.3%)

Beta1.26

S&P 52W Chg14.58%

Avg Vol (30d)2.08M

Avg Vol (10d)2.20M

Technical Indicators

RSI (14)57.2

MACD1.6182

MACD Signal1.2113

MACD Hist.+0.4069

BB Upper67.72 USD

BB Middle59.99 USD

BB Lower52.26 USD

BB Width25.76%

ATR (14)3.001 USD

Vol Ratio (20d)1.03x